Cetera Investment Advisers Boston Scientific Corp Transaction History

Cetera Investment Advisers

$44.2 Billion
Q3 2024

A detailed history of Cetera Investment Advisers transactions in Boston Scientific Corp stock. As of the latest transaction made, Cetera Investment Advisers holds 304,372 shares of BSX stock, worth $27.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

304,372

Previous 295,984 2.83%

Holding current value

$27.7 Million

Previous $22.8 Million 11.9%

% of portfolio

0.06%

Previous 0.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$72.96 - $84.0 $611,988 - $704,592	8,388 Added 2.83%	304,372 $25.5 Million
Q2 2024 Aug 22, 2024	BUY	$67.33 - $77.71 $565,504 - $652,686	8,399 Added 2.92%	295,984 $22.8 Million
Q1 2024 May 24, 2024	BUY	$57.6 - $68.62 $13.7 Million - $16.3 Million	238,003 Added 480.02%	287,585 $19.7 Million
Q1 2024 May 14, 2024	SELL	$57.6 - $68.62 $1.12 Million - $1.33 Million	-19,430 Reduced 28.15%	49,582 $3.4 Million
Q4 2023 Feb 13, 2024	SELL	$48.64 - $57.81 $29,524 - $35,090	-607 Reduced 0.87%	69,012 $3.99 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $115,587 - $125,928	2,303 Added 3.42%	69,619 $3.68 Million
Q2 2023 Aug 09, 2023	BUY	$49.72 - $54.64 $346,150 - $380,403	6,962 Added 11.54%	67,316 $3.64 Million
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $749,756 - $831,898	16,628 Added 38.03%	60,354 $3.02 Million
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $576,310 - $687,900	14,568 Added 49.96%	43,726 $2.02 Million
Q3 2022 Nov 10, 2022	SELL	$36.71 - $109.66 $37,407 - $111,743	-1,019 Reduced 3.38%	29,158 $1.13 Million
Q2 2022 Aug 11, 2022	BUY	$35.24 - $47.1 $48,772 - $65,186	1,384 Added 4.81%	30,177 $1.13 Million
Q1 2022 May 13, 2022	BUY	$40.9 - $45.1 $228,262 - $251,703	5,581 Added 24.04%	28,793 $1.28 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $87,751 - $103,425	2,305 Added 11.03%	23,212 $986,000
Q3 2021 Nov 16, 2021	BUY	$41.23 - $45.88 $57,845 - $64,369	1,403 Added 7.19%	20,907 $907,000
Q2 2021 Aug 13, 2021	BUY	$38.58 - $44.24 $230,939 - $264,820	5,986 Added 44.28%	19,504 $834,000
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $180,264 - $202,753	-5,111 Reduced 27.44%	13,518 $522,000
Q4 2020 Feb 17, 2021	BUY	$33.15 - $41.97 $617,551 - $781,859	18,629 New	18,629 $670,000

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Boston Scientific Corp Transaction History